Roberge Raymond P 4

4 · PRAXAIR INC · Filed Nov 28, 2012

Form 4

Period: 2012-11-26

Senior Vice President

Transactions

Exercise/Conversion
Common Stock
2012-11-26$61.47/sh+12,500$768,375→ 17,170.872 total
Sale
Common Stock
2012-11-26$106.37/sh−12,500$1,329,625→ 4,670.872 total
Exercise/Conversion
Stock Option (right to buy)
2012-11-26−12,500→ 0 total
Exercise: $61.47From: 2008-02-27Exp: 2017-02-27→ Common Stock (12,500 underlying)

Holdings

Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (13,700 underlying)
13,700
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (19,790 underlying)
19,790
Common Stock
(indirect: By 401(k))
70.046
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (21,505 underlying)
21,505
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (27,090 underlying)
27,090
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (20,465 underlying)
20,465
Deferred Stock
Exercise: $0.00→ Common Stock (15,346.334 underlying)
15,346.334

Footnotes (8)

[F1]This total includes shares previously acquired through automatic dividend reinvestment under the Praxair Dividend Reinvestment and Stock Purchase Plan and unvested restricted stock units.
[F2]The $106.37 price reported is the weighted average sale price. The sale prices ranged from $106.220 to $106.498 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
[F3]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
[F4]This option vests over three years in three consecutive equal annual installments beginning on February 23, 2011.
[F5]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
[F6]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
[F7]Conversion to Praxair Common Stock is on a 1-for-1 basis.
[F8]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferred Program") and are to be settled in Praxair Common Stock.

Documents

1 file